Thrombin cleavage of circulating osteopontin in the lung drives hippocampal neuroinflammation and acute delirium-like neurologic dysfunction after acute kidney injury

Acute kidney injury (AKI) is a common clinical problem with high morbidity and mortality due to frequently occurring secondary organ complications, including acute neurologic dysfunction, such as delirium. Specific mechanisms responsible for this kidney-brain crosstalk are unknown but hypothesized to include uremic toxins and neuroinflammation secondary to systemic inflammation. Here we show that uremic mice with AKI show hippocampal monocytic neuroinflammation associated with acute delirium-like neurologic dysfunction only in the presence of circulating osteopontin fragments. Mechanistically, circulating osteopontin (OPN/Spp1) released by the injured kidney was cleaved by thrombin in the lung into OPN-N and OPN-C-terminal fragments. Both OPN fragments were required to drive upregulation of the monocyte chemoattractant chemokine-ligand-2 (CCL2) in hippocampal endothelial cells. AKI mice lacking OPN or unable to activate OPN by thrombin cleavage showed kidney injury and serum uremic toxin elevations like wt controls but were protected from hippocampal CCL2 upregulation, monocyte recruitment, and delirium-like symptoms. Systemic application of an OPN or CCL2 neutralizing antibody was protective. Our results suggest that a specific kidney-released circulating factor, osteopontin, drives acute neurologic dysfunction after AKI and challenge the widely held hypothesis that uremic toxins play a dominant role. They also identify thrombin cleavage of OPN as a potential therapeutic target and critical switch for the remote functions of circulating OPN.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.17.767415
Primary Topic
Acute Kidney Injury Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Thrombin cleavage of circulating osteopontin in the lung drives hippocampal neuroinflammation and acute delirium-like neurologic dysfunction after acute kidney injury

Rupal Ojha, Machiko Honda, John Morser, Liang Ning et al.
5 links
bioRxiv (Cold Spring Harbor Laboratory)
Acute Kidney Injury Research
preprint

Thrombin cleavage of circulating osteopontin in the lung drives hippocampal neuroinflammation and acute delirium-like neurologic dysfunction after acute kidney injury

Rupal Ojha, Machiko Honda, John Morser, Liang Ning, Andreas Herrlich, Shigeyuki Kon, Stuart Howard Friess, Lawrence Leung, Anusha Suresh, Marta Celorrio Navarro, Poornima Dilhani Ekanayake Weerasinghe Mudiyanselage, Leah Tolby
preprint en

Abstract

Acute kidney injury (AKI) is a common clinical problem with high morbidity and mortality due to frequently occurring secondary organ complications, including acute neurologic dysfunction, such as delirium. Specific mechanisms responsible for this kidney-brain crosstalk are unknown but hypothesized to include uremic toxins and neuroinflammation secondary to systemic inflammation. Here we show that uremic mice with AKI show hippocampal monocytic neuroinflammation associated with acute delirium-like neurologic dysfunction only in the presence of circulating osteopontin fragments. Mechanistically, circulating osteopontin (OPN/Spp1) released by the injured kidney was cleaved by thrombin in the lung into OPN-N and OPN-C-terminal fragments. Both OPN fragments were required to drive upregulation of the monocyte chemoattractant chemokine-ligand-2 (CCL2) in hippocampal endothelial cells. AKI mice lacking OPN or unable to activate OPN by thrombin cleavage showed kidney injury and serum uremic toxin elevations like wt controls but were protected from hippocampal CCL2 upregulation, monocyte recruitment, and delirium-like symptoms. Systemic application of an OPN or CCL2 neutralizing antibody was protective. Our results suggest that a specific kidney-released circulating factor, osteopontin, drives acute neurologic dysfunction after AKI and challenge the widely held hypothesis that uremic toxins play a dominant role. They also identify thrombin cleavage of OPN as a potential therapeutic target and critical switch for the remote functions of circulating OPN.

bioRxiv (Cold Spring Harbor Laboratory)
Washington University in St. Louis (US), Fukuyama University (JP), St. Louis VA Medical Center (US), Stanford Medicine (US), John Cochran VA Medical Center (US), VA St. Louis Health Care System (US), Stanford University (US)
Good health and well-being
Acute Kidney Injury Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon